Page 135 - CW E-Magazine (15-10-2024)
P. 135

Point of View



       Eternal vigilance key to maintain incident-free safety

       record of phosgene industry


          Phosgene is an important chemical that finds wide use, both for the manufacture of some large volume chemicals, as well as for
       several small volume ones. The products made from it go to making polymers, agrochemicals, pharmaceuticals, aroma chemicals,
       etc. What makes phosgene stand-out, however, is it hazard. Even at small doses, phosgene is deadly and can cause severe damage
       to the lungs. But that is not to say that the risks cannot be managed. And they are.

          Today, almost all phosgene produced is consumed on site, and there is little or no storage. This mitigates – but does not eliminate –
       a significant portion of the risks associated with its use. To further better safety, a wide body of learning is available from some of
       the major chemical companies that have decades of experience in handling this chemical. What is noteworthy is that these companies
       are open to sharing their experiences with companies less expert. This was evident at the 12th India International Phosgene Safety
       Conference recently held in Vadodara (a detailed report will appear in the October 22 issue). The conference was organised by
       the Indian Phosgene Council (IPC), which is probably the only industry body focused on just one chemical, under the aegis of the
       Indian Chemical Council. The IPC has as its members all major phosgene producers in India (Atul, GNFC, Paushak, and UPL) and the
       international majors (BASF, Covestro and Huntsman) who do not produce phosgene in India but do handle isocyanates.
          Industrially, phosgene is produced by passing purified carbon monoxide and chlorine gas through a bed of porous activated carbon,
       which serves as a catalyst.
          Listed as a Schedule 3 substance under the Chemical Weapons Convention, phosgene is considered too dangerous to transport
       in bulk and is produced/consumed within the same plant, as part of an ‘on demand’ process. This involves maintaining equivalent
       rates of production and consumption, which keeps the amount of phosgene in the system at any time low, reducing risks in the event
       of an accident.

       Isocyanates and polycarbonate
          The most important category of products commercially produced using phosgene are the isocyanates, of which the two most
       important are toluene diisocyanate (TDI) and methylene diphenyl diisocyanate (MDI). While TDI is used to make flexible polyurethane
       (PU) foams, packaging, and textiles, MDI, is more versatile, and used in the production of rigid PU foams (for building/industrial insulation
       and refrigeration), reaction injection-moulding, thermoplastic resins, high-performance elastomers, and spandex fibres, as well as in
       coatings, adhesives, and sealants. Globally, MDI production accounted for ~55% of global phosgene demand (in 2021), with ~27%
       going to make TDI.

          Another large-volume outlet for phosgene is the manufacture of polycarbonate (PC) resin, which is obtained by reacting bisphenol-A (BPA)
       with phosgene. This polymer finds use in industrial equipment parts and electronic components and accounted for ~13% of global
       phosgene consumption in 2021.
          But the phosgene route to PC entails a number of drawbacks in environmental terms, including the toxicity of phosgene, the use of
       the low-boiling-point solvent methylene chloride to which exposure must be restricted, and the large quantity of wastewater containing
       methylene chloride which must be treated. A further incentive to eliminate use of phosgene is the economic penalty incurred because
       the chlorine content of the phosgene is wasted and converted to sodium chloride. Caustic soda is consumed in this conversion and
       the disposal of waste salt solutions presents an ecological problem by itself.

          Today, several PC producers including Sabic, Covestro, Asahi and Mitsubishi Chemical/Mitsubishi Gas Chemical have independently
       developed non-phosgene PC production technologies, based on the trans-esterification of diphenyl carbonate with BPA and using these
       processes (though not exclusively) for PC manufacturing. The non-phosgene routes have gained market share in recent times, and
       given their lower plant construction and feedstock costs, it is expected they will be even more widely adopted. As a consequence,
       the main driver for future phosgene demand increase – expected at a CAGR of ~4-5% – is expected to be production of isocyanates,
       not PC.

       Global markets
          Global phosgene production has risen from ~4-mt in 2000, to about 12-mt in 2020 and is expected to reach ~20-mt by 2030.


       Chemical Weekly  October 15, 2024                                                               135


                                      Contents    Index to Advertisers    Index to Products Advertised
   130   131   132   133   134   135   136   137   138   139   140